Ariadna Cuevas

CIMAvax-EGF regulatory affairs manager at the Centro de Inmunología Molecular (Center for Molecular Immunology)

Articles by Ariadna Cuevas

Fig5_vaccine_peptide_maps_t-557900-1408659477475.jpg

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.

Latest Updated Articles